Back to Search Start Over

Influence of advanced wound matrices on observed vacuum pressure during simulated negative pressure wound therapy.

Authors :
Veale RWF
Kollmetz T
Taghavi N
Duston-Fursman CG
Beeson MT
Asefi D
Chittock HD
Vikranth AS
Dowling SG
Dempsey SG
Rose HJ
Mason ITT
May BCH
Source :
Journal of the mechanical behavior of biomedical materials [J Mech Behav Biomed Mater] 2023 Feb; Vol. 138, pp. 105620. Date of Electronic Publication: 2022 Dec 16.
Publication Year :
2023

Abstract

Biomaterials and negative pressure wound therapy (NPWT) are treatment modalities regularly used together to accelerate soft-tissue regeneration. This study evaluated the impact of the design and composition of commercially available collagen-based matrices on the observed vacuum pressure delivered under NPWT using a custom test apparatus. Specifically, testing compared the effect of the commercial products; ovine forestomach matrix (OFM), collagen/oxidized regenerated cellulose (collagen/ORC) and a collagen-based dressing (CWD) on the observed vacuum pressure. OFM resulted in an ∼50% reduction in the observed target vacuum pressure at 75 mmHg and 125 mmHg, however, this effect was mitigated to a ∼0% reduction when fenestrations were introduced into the matrix. Both collagen/ORC and CWD reduced the observed vacuum pressure at 125 mmHg (∼15% and ∼50%, respectively), and this was more dramatic when a lower vacuum pressure of 75 mmHg was delivered (∼20% and ∼75%, respectively). The reduced performance of the reconstituted collagen products is thought to result from the gelling properties of these products that may cause occlusion of the delivered vacuum to the wound bed. These findings highlight the importance of in vitro testing to establish the impact of adjunctive therapies on NPWT, where effective delivery of vacuum pressure is paramount to the efficacy of this therapy.<br />Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: RWFV, HC, SGD, IM, HJR and BCHM are shareholders of Aroa Biosurgery Limited (Auckland, New Zealand). RWFV, TK, NT, CGD, HC, SGD, SGD, HJR, IM, and BCHM are paid employees of Aroa Biosurgery Limited (Auckland, New Zealand). BCHM is listed as inventor on patent US8415159B2, owned by Aroa Biosurgery Limited.<br /> (Copyright © 2022 Aroa Biosurgery Limited, New Zealand. Published by Elsevier Ltd.. All rights reserved.)

Details

Language :
English
ISSN :
1878-0180
Volume :
138
Database :
MEDLINE
Journal :
Journal of the mechanical behavior of biomedical materials
Publication Type :
Academic Journal
Accession number :
36543083
Full Text :
https://doi.org/10.1016/j.jmbbm.2022.105620